Rebsdorf Medical ApS: Financial statements 2023
CVR: 42080578
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Rebsdorf Medical ApS (CVR 42080578) has filed annual accounts for 2023. In 2023, the company reported a net result of DKK 126,817 compared with DKK -47,996 the year before. Equity in the 2023 report amounted to DKK 40,000. The solvency ratio was 100%.
- Profit/Loss
- DKK 126,817
- Equity
- DKK 40,000
- Total Assets
- DKK 40,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | - | 127K | 40K | - |
| 2022 | - | - | -48K | 40K | - |
| 2021 | -1.3M | 6K | 5K | 40K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Rebsdorf Medical ApS has published its annual report for 2022. The net result was DKK -47,996.
About Rebsdorf Medical ApS
Rebsdorf Medical ApS is a Danish company of the type Anpartsselskab based in Fredericia, founded in 2021. The company is under bankruptcy. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company is owned by Rebsdorf Global Holding ApS. The company has 1 employee (2024). In 2024, the company reported a gross profit of DKK 2,209,669 and a net result of DKK 1,864,374 compared with DKK 126,817 the year before. Equity in the 2024 report amounted to DKK 40,000.
